These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1578669)

  • 1. [Therapeutic apheresis in the treatment of drug-resistant primary glomerulonephritis].
    Sakai S; Sakai O
    Nihon Rinsho; 1992 Jan; 50 Suppl():139-47. PubMed ID: 1578669
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
    Tojo K; Sakai S; Miyahara T
    Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
    [No Abstract]   [Full Text] [Related]  

  • 3. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
    Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
    Tojo K; Sakai S; Miyahara T
    Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1153-60. PubMed ID: 3216557
    [No Abstract]   [Full Text] [Related]  

  • 5. What is new in therapy of glomerulonephritis in 2003/2004.
    Hruby Z
    Rocz Akad Med Bialymst; 2004; 49():166-9. PubMed ID: 15631335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of primary glomerulonephritis].
    Nagy J
    Orv Hetil; 2005 Jan; 146(4):169-73. PubMed ID: 15751512
    [No Abstract]   [Full Text] [Related]  

  • 7. [LDL-apheresis for refractory nephrotic syndrome].
    Muso E
    Nihon Jinzo Gakkai Shi; 2010; 52(7):928-33. PubMed ID: 21077343
    [No Abstract]   [Full Text] [Related]  

  • 8. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
    Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K
    Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryofiltration apheresis for treatment of cryoglobulin-induced glomerulonephritis in renal transplant.
    Siami GA; Siami FS
    Transplant Proc; 1995 Oct; 27(5):2583-4. PubMed ID: 7482837
    [No Abstract]   [Full Text] [Related]  

  • 10. LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy.
    Yokoyama K; Sakai S; Sigematsu T; Takemoto F; Hara S; Yamada A; Kawaguchi Y; Hosoya T
    Clin Nephrol; 1998 Jul; 50(1):1-7. PubMed ID: 9710340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rapidly progressive glomerulonephritis treated by apheresis. A major economic challenge].
    Branger B; Zabadani B; Vécina F; Mayor MM; Fourcade J
    Ann Med Interne (Paris); 1994; 145(5):376-80. PubMed ID: 7985954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
    Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M
    Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP
    J Nephrol; 1999; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic advances in glomerular nephropathies].
    Pérez García R
    Rev Clin Esp; 1991 Nov; 189(7):305-8. PubMed ID: 1767085
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful renal transplantation in focal segmental glomerulosclerosis.
    Currier CB; Papadopoulou Z; Helfrich GB; Diaz MH; Sulkin MD
    Transplant Proc; 1979 Mar; 11(1):49-54. PubMed ID: 377682
    [No Abstract]   [Full Text] [Related]  

  • 16. Recovery of Kidney Function Among Patients With Glomerular Disease Starting Maintenance Dialysis.
    Kwong YD; Liu KD; Hsu RK; Johansen KL; McCulloch CE; Seth D; Fallahzadeh MK; Grimes BA; Ku E
    Am J Kidney Dis; 2021 Feb; 77(2):303-305. PubMed ID: 32771649
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
    J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of low-density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy.
    Tanaka A; Nakamura T; Sato E; Node K
    Nephrology (Carlton); 2016 Dec; 21(12):1073-1074. PubMed ID: 27870230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Focal mesangioproliferative glomerulonephritis].
    Riabov SI; Klemina IK; Plotkin VIa
    Ter Arkh; 1983; 55(6):14-9. PubMed ID: 6225209
    [No Abstract]   [Full Text] [Related]  

  • 20. Spontaneous remission of proteinuria in recurrent focal glomerulosclerosis. Reappraisal of plasma exchange treatment.
    Franco A; Peres R; Anaya F; Niembro E; Valderrabano
    Clin Nephrol; 1987 Sep; 28(3):158. PubMed ID: 3311505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.